In the population of tumor-infiltrating CD8+ T lymphocytes, effector memory CD62L-CD44+ cells were significantly increased (65.1%), while exhausted PD-1+ cells were significantly reduced (45.95%), in mice vaccinated with Dexo(B16 + pIC) (Fig. 5f, left). This evidence concerns the gene CD8A and neoplasm.